CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content


Last Updated: May 3, 2011
Result type: Reports
Project Number: SR0231-000
Product Line: Reimbursement Review

Generic Name: Boceprevir

Brand Name: Victrelis

Manufacturer: Merck Canada Inc.

Therapeutic Area: Hepatitis C, chronic

Indications: Hepatitis C, chronic

Submission Type: Initial

Project Status: Complete

Date Recommendation Issued: October 24, 2011

Recommendation Type: List with clinical criteria and/or conditions